Product Information

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by SpecGx LLC, priced at $0.1379 per EA under NDC 00406012412. Its NADAC has been published 452 times since Sep 13, 2017.

FDA first approved this application on Sep 8, 2000. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET

HYDROCODONE BITARTRATE AND ACETAMINOPHEN
$0.1379per EA
DEA Schedule CII

Strength

325; 7.5 mg/1; mg/1

Manufacturer

SpecGx LLC

NDC

00406012412

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040405

FDA Approved

9/8/2000

TE Code

AA

On Market Since

9/8/2000

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 452 times since Sep 13, 2017, and over the history we have for it it has declined 20.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1379 per EA
All-time high$0.1736 (Sep 13, 2017)
All-time low$0.0932 (Dec 18, 2019)
52-week high$0.1522
52-week low$0.1379
Median price$0.1321
Average price$0.1316
Largest weekly change+41.5% (Jan 22, 2020)
Weeks tracked452
Tracking sinceSep 13, 2017

Price History

1W

N/A

1M

N/A

3M

N/A

6M

-1.3%

1Y

-9.4%

3Y

+7.5%

5Y

+13.0%

All

-20.6%

Last surveyed May 6, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 2%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by SpecGx LLC, is $0.1379 per EA (NDC 00406012412), effective May 6, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 20.6%. It has been tracked across 452 weekly CMS publications since Sep 13, 2017.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Since Sep 13, 2017, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.0932 (Dec 18, 2019) to a high of $0.1736 (Sep 13, 2017), with a median of $0.1321 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, is $0.1354 per EA — about 2% below HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 00406012412) is labeled by SpecGx LLC, and CMS classifies it as a generic product.